Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a6907c0df7c11e72803b375909e45fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9494c30f8f6cb9e15dc21e0d6895855 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 |
filingDate |
2007-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2008-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fba409fd58742cc3f13f55ce548eba1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ffef836579578b50a5fb4d436cdaa63 |
publicationDate |
2008-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2332205-C1 |
titleOfInvention |
Method of thromboplastin formation for patients with metabolic syndrome |
abstract |
FIELD: medicine. n SUBSTANCE: treatment includes individual hypocalorific diet, sensibly graduated static and dynamic physical activities. Also 500 mg of metformin 2 times per day, 80 mg of valsartan once per day, and 25 mg of hydrochlorthiazide in the mornings are prescribed. The treatment course takes 6 months. n EFFECT: possibility to avoid complications in hemostatic system. n 1 ex |
priorityDate |
2007-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |